Publicacións en colaboración con investigadores/as de University of Bern (24)

2024

  1. Mosquitocidal efficacy and pharmacokinetics of single-dose ivermectin versus three-day dose regimen for malaria vector control compared with albendazole and no treatment: An open-label randomized controlled trial

    International Journal of Infectious Diseases, Vol. 148

  2. Progress in the Treatment of Alzheimer’s Disease Is Needed – Position Statement of European Alzheimer’s Disease Consortium (EADC) Investigators

    Journal of Prevention of Alzheimer's Disease

2023

  1. Genetic reanalysis of patients with a difference of sex development carrying the NR5A1/SF-1 variant p.Gly146Ala has discovered other likely disease-causing variations

    PloS one, Vol. 18, Núm. 7, pp. e0287515

  2. Pharmacokinetics of ivermectin metabolites and their activity against Anopheles stephensi mosquitoes

    Malaria Journal, Vol. 22, Núm. 1

2022

  1. Eating behaviors and health-related quality of life: A scoping review

    Maturitas, Vol. 165, pp. 58-71

  2. Effectiveness of Antiviral Therapy in Highly-Transmissible Variants of SARS-CoV-2: A Modeling and Simulation Study

    Frontiers in Pharmacology, Vol. 13

  3. Genetic and pharmacological inhibition of XBP1 protects against APAP hepatotoxicity through the activation of autophagy

    Cell death & disease, Vol. 13, Núm. 2, pp. 143

  4. Oncoplastic breast consortium recommendations for mastectomy and whole breast reconstruction in the setting of post-mastectomy radiation therapy

    Breast, Vol. 63, pp. 123-139

  5. Variations in management of A3 and A4 cervical spine fractures as designated by the AO Spine Subaxial Injury Classification System

    Journal of Neurosurgery: Spine, Vol. 36, Núm. 1, pp. 99-112

2021

  1. Abnormal liver function test in patients infected with coronavirus (Sars-cov-2): A retrospective single-center study from spain

    Journal of Clinical Medicine, Vol. 10, Núm. 5, pp. 1-18

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  3. Modeling of SARS-CoV-2 Treatment Effects for Informed Drug Repurposing

    Frontiers in Pharmacology, Vol. 12

2020

  1. Recent advances in alcohol-related liver disease (ALD): Summary of a Gut round table meeting

    Gut, Vol. 69, Núm. 4, pp. 764-780

  2. Urticaria: Collegium Internationale Allergologicum (CIA) Update 2020

    International Archives of Allergy and Immunology, Vol. 181, Núm. 5, pp. 321-333

2018

  1. Gut roundtable meeting paper: Selected recent advances in hepatocellular carcinoma

    Gut, Vol. 67, Núm. 2, pp. 380-388

  2. Magnetic resonance imaging biomarkers for chronic kidney disease: a position paper from the European Cooperation in Science and Technology Action PARENCHIMA

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 33, Núm. 2, pp. ii4-ii14

2017

  1. The anticoagulant rivaroxaban lowers portal hypertension in cirrhotic rats mainly by deactivating hepatic stellate cells

    Hepatology, Vol. 65, Núm. 6, pp. 2031-2044

2016

  1. Assessment of the Hong Kong Liver Cancer Staging System in Europe

    Liver International, Vol. 36, Núm. 6, pp. 911-917

  2. Basophil activation testing in diagnosis and monitoring of allergic disease - An overview

    Allergo Journal, Vol. 25, Núm. 4, pp. 26-33

  3. Basophil activation testing in diagnosis and monitoring of allergic disease – an overview

    Allergo Journal International, Vol. 25, Núm. 4, pp. 106-113